Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

European Society
For Medical Oncology

The leading professional organisation for medical oncology

Late registration deadline approaching
Late registration deadline approaching

ESMO World GI 2023

Enhance your knowledge and advance the treatment and management of cancers of the GI tract. Join us in Barcelona on 28 June – 1 July.

Register by 9 June and save!
Registration now open
Registration now open

ESMO Asia 2023

Meet Asian and international key opinion leaders in the entire field of oncology on 1-3 December in Singapore and discover the latest breakthroughs in cancer research and treatment.

Register now and save!
Open to all Oncologists
Open to all Oncologists

Cancer of Unknown Primary: Access Now

Which treatment to choose for malignancies of undefined primary origin? Listen to the experts developing and implementing the ESMO Guidelines to discover how these can assist your decision-making

Webinar Resources
ESMO-MCBS 1000x1000


A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.

Discover more

Latest News

More Oncology News More Press Releases More Society Updates Read the ESMO Daily Reporter
More Oncology News
Press Releases Event Announcement

ESMO Breast Cancer Congress 2023

The ESMO Breast Cancer Congress 2023, will be held onsite in Berlin, Germany, and online, through a virtual platform, between 11-13 May 2023

Press Releases Event Announcement

ESMO Targeted Anticancer Therapies Congress 2023

The ESMO Targeted Anticancer Therapies Congress 2023, the gathering focusing on promising new anticancer targets and agents, with a particular emphasis on those in early phase clinical development, will be held in Paris, France, on 6-8 March 2023.

Press Releases Event Announcement

ESMO Gynaecological Cancers Congress 2023

The ESMO Gynaecological Cancers Congress 2023, the annual event dedicated to improving the practice of gynaecological cancers specialists worldwide, will provide an overview of the latest treatments as well as insights into the biology and biomarkers of ovarian, uterine, cervical and even rare gynaecological cancers.

Press Releases Event Announcement

ESMO Immuno-Oncology Congress 2022, 7-9 December, Geneva, Switzerland

The ESMO Immuno-Oncology Congress 2022, an annual congress dedicated to the presentation and discussion of the latest scientific developments in this fast-moving field, will be held in person in Geneva, Switzerland, and virtually between 7-9 December.

More Press Releases
Society Updates Society Updates

Supporting Oncologists at the Point of Care: ESMO Living Guidelines

ESMO launched the ESMO Living Guidelines, a new tool designed to make the ESMO Clinical Practice Guidelines (CPGs) easier to use in oncologists’ routine clinical practice and support optimal decision-making in a rapidly evolving medical field

Society Updates Society Updates

2023 ESMO Breast Cancer Award Recipient Announced

The European Society for Medical Oncology (ESMO) has announced today that the 2023 ESMO Breast Cancer Award is bestowed to Sara A. Hurvitz for her remarkable contributions to breast cancer clinical and laboratory-based research

Society Updates Society Updates

2023 Heine H. Hansen Award Recipient Announced

The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced today that the 2023 Heine H. Hansen Award is conferred on Paul Baas for his outstanding contribution to thoracic oncology research

Society Updates Society Updates

ESMO Supports World Cancer Day 2023

ESMO renews its support to World Cancer Day (WCD) joining the #CloseTheCareGap campaign led by the Union for International Cancer Control (UICC). 

More Society Updates
Daily Reporter

Breast cancer leads the way in ADC therapy

Lessons learned from the use of second-generation antibody–drug conjugates (ADCs) in breast cancer can direct treatment in other tumour types 

Read the ESMO Daily Reporter

Congress Scientific Watch

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.